Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRBP Corbus Pharmaceuticals

Post-Mkt 05-22 17:03:41 EDT

11.35

-0.16

-1.39%

盘后11.27

-0.08-0.70%

16:37 EDT

High12.88	Low11.26	Vol556.30K
Open11.46	D1 Closing11.51	Amplitude14.08%
Mkt Cap210.29M	Tradable Cap153.60M	Total Shares18.53M
T/O6.63M	T/O Rate4.11%	Tradable Shares13.53M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals","latestPrice":11.35,"timestamp":1779480000000,"preClose":11.51,"halted":0,"volume":556301,"hourTrading":{"tag":"盘后","latestPrice":11.2709,"preClose":11.35,"latestTime":"16:37 EDT","volume":2387,"amount":27080.219011999998,"timestamp":1779482224816,"change":-0.0791,"changeRate":-0.006969,"amplitude":0.010493},"delay":0,"changeRate":-0.013900955690703749,"floatShares":13532800,"shares":18527795,"eps":-5.660431,"marketStatus":"Post-Mkt","change":-0.16,"latestTime":"05-22 17:03:41 EDT","open":11.46,"high":12.8808,"low":11.26,"amount":6625740.171651,"amplitude":0.140817,"askPrice":12.5,"askSize":100,"bidPrice":11.2,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-5.660431,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1779494400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":11.51,"preHourTrading":{"tag":"盘前","latestPrice":10.98,"preClose":11.51,"latestTime":"09:29 EDT","volume":3629,"amount":40469.189061000005,"timestamp":1779456556026,"change":-0.53,"changeRate":-0.046047,"amplitude":0.078193},"postHourTrading":{"tag":"盘后","latestPrice":11.2709,"preClose":11.35,"latestTime":"16:37 EDT","volume":2387,"amount":27080.219011999998,"timestamp":1779482224816,"change":-0.0791,"changeRate":-0.006969,"amplitude":0.010493},"volumeRatio":1.667578,"impliedVol":0.9034,"impliedVolPercentile":0.4263},"requestUrl":"/m/hq/s/CRBP/tweets","defaultTab":"tweets","newsList":[{"id":"2637311321","title":"Corbus Pharmaceuticals Is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311321","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637311321?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:08","pubTimestamp":1779451680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 22, 2026 08:08 ET (12:08 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637319215","title":"Mizuho Adjusts Price Target on Corbus Pharmaceuticals to $44 From $40, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2637319215","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637319215?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:55","pubTimestamp":1779450911,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals (CRBP) has an average rating of buy and mean price target of $41.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MFG","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637395298","title":"U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday","url":"https://stock-news.laohu8.com/highlight/detail?id=2637395298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637395298?lang=en_us&edition=fundamental","pubTime":"2026-05-22 14:49","pubTimestamp":1779432553,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, WorkdayMay 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Jazz P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nL4N41Z0HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MVLL","NUE","ROST","FDX","JAZZ","AAP","WMTI","MRVU","RL","ZM","LLY","CMC","LLII","STLD","SMMT","RIOT","MP","FCX","WSM","DELL","DLLL","EHC","SPG","MRVL","TOL","HLNE","NEMG","FENC","LLYX","CLF","SUI","ELIL","WDAY","FRT","MTSI","WMT","INTU","MAIN","TGT","CRBP","NEM","NCLH","DE","ELIS","QTTB","SCCO","EL","BEAT","WMS","RTYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357160","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357160","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357160?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:23","pubTimestamp":1779398580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  surged 18.29% to $11.51 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.09% to 26,293.10 and the Dow Jones Industrial Average  rising 0.55% to 50,285.66.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 44.02% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  rose 0.49% to $6.21, Fortress Biotech Inc.  rose 4.91% to $2.78, and Viking Therapeutics Inc.  rose 4.21% to $30.68.Trading volume  eclipsed its 50-day average volume of 258,541.Data source: Dow Jones Market Data, FactSet. Data compiled May 21, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352008","title":"Corbus Pharma director Brent Pfeiffenberger files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352008","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352008?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:03","pubTimestamp":1779397399,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals filed an initial beneficial ownership statement naming Brent Pfeiffenberger as a director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL7p2Qpb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637339582","title":"Corbus Pharmaceuticals Appoints First Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637339582","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637339582?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:59","pubTimestamp":1779368348,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Corbus Pharmaceuticals ( ($CRBP) ). On May 21, 2026, Corbus Pharmaceuticals appointed former Evercore managing ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-appoints-first-chief-business-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-appoints-first-chief-business-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637477333","title":"Corbus Pharma names Nishant Saxena chief business officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637477333","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637477333?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:01","pubTimestamp":1779364875,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals named Nishant Saxena as its first chief business officer as it moves toward registrational-stage development for its lead programs.Saxena was most recently chief financial officer at Jeune Aesthetics, a unit of Krystal Biotech.He previously spent more than 15 years at Evercore, most recently as a managing director in the healthcare group advising on mergers, acquisitions, financings, and partnerships.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL9PXsTn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4127","CRBP","BK4139","EVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637252333","title":"Corbus Pharmaceuticals Holdings Inc - to Initiate Registrational Study for Crb-701 in Second-Line Hnscc This Summer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637252333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637252333?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:00","pubTimestamp":1779364804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA6BHMVD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637033310","title":"Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 Asco Crb-701 Data Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2637033310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637033310?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:00","pubTimestamp":1779364804,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA6BHMVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333084","title":"Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333084","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333084?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:00","pubTimestamp":1779364800,"startTime":"0","endTime":"0","summary":"NORWOOD, Mass., May  21, 2026  (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299267/0/en/Corbus-Pharmaceuticals-Announces-the-Appointment-of-Nishant-Saxena-as-Chief-Business-Officer-and-Schedules-a-Pre-2026-ASCO-CRB-701-Data-Conference-Call.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4139","KRYS","CRBP","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637876346","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2637876346","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637876346?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:20","pubTimestamp":1779312000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 6.34% to $9.73 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 1.54% to 26,270.36 and the Dow Jones Industrial Average  rising 1.31% to 50,009.35.The stock's rise snapped a four-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 52.68% below its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 3.17% to $6.18, Fortress Biotech Inc.  rose 4.74% to $2.65, and Viking Therapeutics Inc.  rose 3.66% to $29.44.Trading volume  eclipsed its 50-day average volume of 261,108.Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published in","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636586782","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2636586782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636586782?lang=en_us&edition=fundamental","pubTime":"2026-05-20 05:19","pubTimestamp":1779225540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 8.04% to $9.15 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.84% to 25,870.71 and Dow Jones Industrial Average  falling 0.65% to 49,363.88.This was the stock's fourth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 55.50% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 1.48% to $5.99, Fortress Biotech Inc.  rose 2.02% to $2.53, and Viking Therapeutics Inc.  fell 1.01% to $28.40.Trading volume  eclipsed its 50-day average volume of 264,933.Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636941009","title":"Corbus Pharmaceuticals Holdings Inc. Stock Falls 9.8%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2636941009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636941009?lang=en_us&edition=fundamental","pubTime":"2026-05-19 04:33","pubTimestamp":1779136380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. shed 9.8% to $9.95 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 49,686.12 and the NASDAQ Composite Index falling 0.5% to 26,090.73.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 51.6% short of its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 3.2% to $6.08, Fortress Biotech Inc. rose 2.9% to $2.48, and Viking Therapeutics Inc. fell 5.22% to $28.69.Trading volume totaled 232,426, compared to the 50-day average of 263,554.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635547066","title":"Corbus Pharmaceuticals (CRBP) Receives a Buy from LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2635547066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635547066?lang=en_us&edition=fundamental","pubTime":"2026-05-16 22:36","pubTimestamp":1778942190,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Oliver McCammon maintained a Buy rating on Corbus Pharmaceuticals today and set a price target of $38.00. According to TipR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/corbus-pharmaceuticals-crbp-receives-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/corbus-pharmaceuticals-crbp-receives-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729097","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729097?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:20","pubTimestamp":1778793600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 1.40% to $11.98 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.88% to 26,635.22 and the Dow Jones Industrial Average  rising 0.75% to 50,063.46.The stock's fall snapped a four-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 41.73% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 0.62% to $6.39, Fortress Biotech Inc.  rose 3.14% to $2.30, and Viking Therapeutics Inc.  rose 0.03% to $31.71.Trading volume  remained 47,095 below its 50-day average volume of 264,952.Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2026.This content was created by MarketWatch, which is operated by Dow J","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635440710","title":"Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635440710","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635440710?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:48","pubTimestamp":1778762920,"startTime":"0","endTime":"0","summary":"An announcement from Corbus Pharmaceuticals ( ($CRBP) ) is now available. On May 13, 2026, Corbus Pharmaceuticals’ board appointed veteran pharma e...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-adds-independent-director-amid-governance-updates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-adds-independent-director-amid-governance-updates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635128527","title":"Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2635128527","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635128527?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760005,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA4SDRXK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBP","IPSC","BK4139","BK4505","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635373820","title":"Corbus Pharmaceuticals Price Target Maintained With a $45.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2635373820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635373820?lang=en_us&edition=fundamental","pubTime":"2026-05-13 22:04","pubTimestamp":1778681040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2026 10:04 ET (14:04 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635787487","title":"Oppenheimer Adjusts Price Target on Corbus Pharmaceuticals to $54 From $57, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2635787487","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635787487?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:01","pubTimestamp":1778677307,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings Inc (CRBP) has an average rating of buy and mean price target of $40.78, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic res","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635785782","title":"Wedbush Remains a Buy on Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635785782","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635785782?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:39","pubTimestamp":1778675977,"startTime":"0","endTime":"0","summary":"In a report released today, from Wedbush reiterated a Buy rating on Corbus Pharmaceuticals, with a price target of $38.00. In a report released tod...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-remains-a-buy-on-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-remains-a-buy-on-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0392},{"period":"1month","weight":0.118},{"period":"3month","weight":0.5512},{"period":"6month","weight":-0.0416},{"period":"1year","weight":0.5533},{"period":"ytd","weight":0.414}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":0.0549},{"period":"3month","weight":0.0773},{"period":"6month","weight":0.127},{"period":"1year","weight":0.2743},{"period":"ytd","weight":0.0892}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.363358},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.048678},{"month":3,"riseRate":0.636364,"avgChangeRate":0.197993},{"month":4,"riseRate":0.545455,"avgChangeRate":0.046477},{"month":5,"riseRate":0.666667,"avgChangeRate":0.086335},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.065346},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.050382},{"month":8,"riseRate":0.636364,"avgChangeRate":0.095672},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.086452},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.124298},{"month":11,"riseRate":0.727273,"avgChangeRate":0.130055},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.132264}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corbus Pharmaceuticals,CRBP,Corbus Pharmaceuticals股票,Corbus Pharmaceuticals股票老虎,Corbus Pharmaceuticals股票老虎国际,Corbus Pharmaceuticals行情,Corbus Pharmaceuticals股票行情,Corbus Pharmaceuticals股价,Corbus Pharmaceuticals股市,Corbus Pharmaceuticals股票价格,Corbus Pharmaceuticals股票交易,Corbus Pharmaceuticals股票购买,Corbus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}